Abstract
The authors report their experience with thalidomide in the treatment of a bilateral chronic idiopathic uveitis, in a 3-year-old female. This case was complicated by the presence of a cataract and an iris neovascularization in the right eye; furthermore it was partially unresponsive to a conventional anti-inflammatory and immunosuppressive therapy. Oral thalidomide induced slow but dramatic regression of the inflammation, and a significant reabsorption of neovascular tufts, both in slitlamp examination and on iris fluorescein angiography. The authors emphasize the efficacy of thalidomide as anti-inflammatory agent and as inhibitor of neoangiogenesis, reporting the recent literature about the use of this drug in ophthalmology.
Original language | English |
---|---|
Pages (from-to) | 70-73 |
Number of pages | 4 |
Journal | Ophthalmologica |
Volume | 215 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2001 |
Keywords
- Children
- Thalidomide
- Uveitis
ASJC Scopus subject areas
- Ophthalmology